IRIC discoveries have spurred major advances in understanding the development of cancer and opened the way to the creation of new, more targeted therapeutic solutions. Its publications are a reflection of these accomplishments. They also demonstrate the Institute’s drive and productivity.
UM171 Enhances Lentiviral Gene Transfer and Recovery of Primitive Human Hematopoietic Cells.Mol Ther Methods Clin Dev 2018-09-21;10:156-164.
Meet the Editors: Pierre Thibault.Rapid Commun. Mass Spectrom. 2018-08-30;32(16):1320-1321.
Type 2 diabetes-associated variants of the MT melatonin receptor affect distinct modes of signaling.Sci Signal 2018-08-28;11(545).
BRAF/MAPK and GSK3 signaling converges to control MITF nuclear export.Proc. Natl. Acad. Sci. U.S.A. 2018-08-27.
Real-time tracking of complex ubiquitination cascades using a fluorescent confocal on-bead assay.BMC Biol. 2018-08-10;16(1):88.
Identification of beta-arrestin-1 as a diagnostic biomarker in lung cancer.Br. J. Cancer 2018-08-06.
A unified view of spatio-temporal control of mitotic entry: Polo kinase as the key.Open Biol 2018-08-01;8(8).
High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia.Blood Cancer J 2018-07-19;8(8):68.
Incorporation of histone deacetylase inhibitory activity into the core of tamoxifen - A new hybrid design paradigm.Bioorg. Med. Chem. 2018-07-17.